Total Payments
$3,911
2024 Payments
$688.03
Companies
22
Transactions
42
Medicare Patients
754
Medicare Billing
$76,476
Payment Breakdown by Category
Food & Beverage$3,911 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,911 | 42 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $732.20 | 6 | $0 (2019) |
| Aerie Pharmaceuticals, Inc. | $605.99 | 5 | $0 (2021) |
| Tarsus Pharmaceuticals, Inc. | $295.67 | 3 | $0 (2024) |
| Abbott Laboratories | $282.69 | 2 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $254.10 | 2 | $0 (2021) |
| TISSUETECH, INC. | $166.33 | 3 | $0 (2021) |
| OCULUS, Inc. | $155.77 | 1 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $135.00 | 1 | $0 (2024) |
| AbbVie, Inc. | $125.00 | 1 | $0 (2017) |
| Gilead Sciences Inc | $125.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $688.03 | 11 | Tarsus Pharmaceuticals, Inc. ($295.67) |
| 2023 | $152.29 | 2 | Abbott Laboratories ($125.00) |
| 2022 | $261.87 | 2 | Abbott Laboratories ($157.69) |
| 2021 | $384.41 | 5 | SUN PHARMACEUTICAL INDUSTRIES INC. ($125.00) |
| 2019 | $988.00 | 8 | Allergan Inc. ($373.00) |
| 2018 | $733.70 | 8 | Aerie Pharmaceuticals, Inc. ($237.01) |
| 2017 | $702.73 | 6 | Sun Pharmaceutical Industries Inc. ($129.10) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $22.52 | General |
| 11/26/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $22.52 | General |
| 10/29/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: Ophthalmology | ||||||
| 10/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $81.87 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/20/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: SOLUTION/ DROPS | ||||||
| 05/29/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $119.58 | General |
| Category: IMMUNOLOGY | ||||||
| 04/06/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $71.61 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/05/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $142.19 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 03/28/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Rare Disease | ||||||
| 02/23/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Ophthalmology | ||||||
| 01/25/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/21/2023 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Ophthalmology | ||||||
| 06/28/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES CARE | ||||||
| 09/15/2022 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $104.18 | General |
| 07/28/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $157.69 | General |
| Category: Diabetes Care | ||||||
| 11/09/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 07/13/2021 | Eyevance Pharmaceuticals LLC | Tobradex ST (Drug) | Food and Beverage | In-kind items and services | $94.97 | General |
| Category: Anti-Infective/Steroid | ||||||
| 07/08/2021 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $124.34 | General |
| Category: Glaucoma | ||||||
| 05/18/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 03/17/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 12/04/2019 | Horizon Therapeutics plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: RAYOS | ||||||
| 10/23/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $124.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/21/2019 | Sight Sciences, Inc. | OMNI (Device) | Food and Beverage | In-kind items and services | $89.60 | General |
| Category: Ophthalmology | ||||||
| 09/26/2019 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DRY EYE | ||||||
| 09/11/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $123.66 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 222 | 333 | $81,238 | $23,770 |
| 2022 | 9 | 193 | 284 | $68,695 | $19,846 |
| 2021 | 7 | 204 | 266 | $61,594 | $19,403 |
| 2020 | 7 | 135 | 181 | $43,735 | $13,457 |
Total Patients
754
Total Services
1,064
Medicare Billing
$76,476
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 27 | 100 | $35,108 | $8,685 | 24.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 32 | 32 | $9,278 | $2,952 | 31.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 24 | 38 | $7,631 | $2,917 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 27 | $6,803 | $2,694 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 32 | $5,505 | $2,548 | 46.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 28 | 32 | $4,903 | $1,443 | 29.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,657 | $1,174 | 25.2% |
| 92250 | Photography of the retina | Office | 2023 | 39 | 40 | $6,314 | $1,017 | 16.1% |
| 92285 | Photography of content of eyes | Office | 2023 | 20 | 20 | $1,038 | $340.34 | 32.8% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 21 | 70 | $24,576 | $6,508 | 26.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 27 | 61 | $12,250 | $4,425 | 36.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 29 | 29 | $8,408 | $2,538 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 17 | $4,283 | $1,835 | 42.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $5,821 | $1,754 | 30.1% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 26 | 27 | $4,137 | $1,442 | 34.9% |
| 92250 | Photography of the retina | Office | 2022 | 35 | 37 | $5,841 | $929.43 | 15.9% |
| 92285 | Photography of content of eyes | Office | 2022 | 14 | 15 | $778.80 | $234.31 | 30.1% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 13 | 13 | $2,600 | $180.62 | 6.9% |
| 68761 | Closure of tear duct opening using plug | Office | 2021 | 18 | 45 | $15,799 | $4,389 | 27.8% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 27 | 53 | $10,643 | $4,151 | 39.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 29 | 29 | $11,254 | $3,819 | 33.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 33 | 35 | $10,148 | $3,459 | 34.1% |
| 92250 | Photography of the retina | Office | 2021 | 47 | 53 | $8,367 | $1,595 | 19.1% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 27 | 27 | $4,137 | $1,545 | 37.4% |
| 92285 | Photography of content of eyes | Office | 2021 | 23 | 24 | $1,246 | $444.90 | 35.7% |
About Dr. David Alevi, MD
Dr. David Alevi, MD is a Ophthalmology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2012. The National Provider Identifier (NPI) number assigned to this provider is 1669730974.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Alevi, MD has received a total of $3,911 in payments from pharmaceutical and medical device companies, with $688.03 received in 2024. These payments were reported across 42 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,911).
As a Medicare-enrolled provider, Alevi has provided services to 754 Medicare beneficiaries, totaling 1,064 services with total Medicare billing of $76,476. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Bronx, NY
- Active Since 04/25/2012
- Last Updated 01/31/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669730974
Products in Payments
- Rhopressa (Drug) $481.65
- LUMIGAN (Drug) $373.00
- XDEMVY (Drug) $295.67
- RESTASIS (Drug) $250.00
- ACTHAR (Biological) $209.99
- FREESTYLE LIBRE 2 (Device) $157.69
- OCULUS Pentacam (Device) $155.77
- ULTOMIRIS (Biological) $135.00
- Bromsite (Drug) $129.10
- Prokera (Device) $126.23
- Cequa (Drug) $125.00
- Epclusa (Drug) $125.00
- FREESTYLE LIBRE 3 (Device) $125.00
- Humira (Biological) $125.00
- RAYOS (Drug) $124.99
- rocklatan (Drug) $124.34
- Vivitrol 380 mg (Drug) $108.22
- Tobradex ST (Drug) $94.97
- OMNI (Device) $89.60
- Izervay (Drug) $71.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Bronx
Roy Chuck, M.d, M.D
Ophthalmology — Payments: $27,925
Ophthalmology $27,925
Michael Pisacano, Md, MD
Ophthalmology — Payments: $14,876
Ophthalmology $14,876
John Kim, Md, MD
Ophthalmology — Payments: $12,780
Ophthalmology $12,780
Fiona Pathay, Md, MD
Ophthalmology — Payments: $10,071
Ophthalmology $10,071
Dr. Anthony Terraciano, Md, MD
Ophthalmology — Payments: $10,043
Ophthalmology $10,043
Dr. Eric Wolf, M.d, M.D
Ophthalmology — Payments: $5,687
Ophthalmology $5,687